Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Knepper, Paul A
NCT05062486: A Study to Evaluate the Safety and Efficacy of RQC for AMD	Recruiting	2	150	US	Resveratrol, Quercetin, Curcumin (RQC), Curcumin	Paul A Knepper, MD PhD	Age-related Macular Degeneration	02/23	02/23
NCT06470061: RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β	Not yet recruiting	2	200	US	Resveratrol, Quercetin, and Curcumin (RQC), Resveratrol, Quercetin, and Curcumin, Curcumin	Zaparackas and Knepper LTD, Northwestern University Feinberg School of Medicine	Alzheimer Disease, Mild Cognitive Impairment, Cognitive Decline	07/27	07/27
Aman, Stephanie
NCT05062486: A Study to Evaluate the Safety and Efficacy of RQC for AMD	Recruiting	2	150	US	Resveratrol, Quercetin, Curcumin (RQC), Curcumin	Paul A Knepper, MD PhD	Age-related Macular Degeneration	02/23	02/23
NCT06470061: RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β	Not yet recruiting	2	200	US	Resveratrol, Quercetin, and Curcumin (RQC), Resveratrol, Quercetin, and Curcumin, Curcumin	Zaparackas and Knepper LTD, Northwestern University Feinberg School of Medicine	Alzheimer Disease, Mild Cognitive Impairment, Cognitive Decline	07/27	07/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Knepper, Paul A
NCT05062486: A Study to Evaluate the Safety and Efficacy of RQC for AMD	Recruiting	2	150	US	Resveratrol, Quercetin, Curcumin (RQC), Curcumin	Paul A Knepper, MD PhD	Age-related Macular Degeneration	02/23	02/23
NCT06470061: RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β	Not yet recruiting	2	200	US	Resveratrol, Quercetin, and Curcumin (RQC), Resveratrol, Quercetin, and Curcumin, Curcumin	Zaparackas and Knepper LTD, Northwestern University Feinberg School of Medicine	Alzheimer Disease, Mild Cognitive Impairment, Cognitive Decline	07/27	07/27
Aman, Stephanie
NCT05062486: A Study to Evaluate the Safety and Efficacy of RQC for AMD	Recruiting	2	150	US	Resveratrol, Quercetin, Curcumin (RQC), Curcumin	Paul A Knepper, MD PhD	Age-related Macular Degeneration	02/23	02/23
NCT06470061: RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β	Not yet recruiting	2	200	US	Resveratrol, Quercetin, and Curcumin (RQC), Resveratrol, Quercetin, and Curcumin, Curcumin	Zaparackas and Knepper LTD, Northwestern University Feinberg School of Medicine	Alzheimer Disease, Mild Cognitive Impairment, Cognitive Decline	07/27	07/27